Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Dividends Paid - Common (2016 - 2023)

Historic Dividends Paid - Common for Ernexa Therapeutics (ERNA) over the last 7 years, with Q4 2023 value amounting to $8000.0.

  • Ernexa Therapeutics' Dividends Paid - Common changed 0.0% to $8000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $16000.0, marking a year-over-year change of. This contributed to the annual value of $16000.0 for FY2023, which is 0.0% changed from last year.
  • Latest data reveals that Ernexa Therapeutics reported Dividends Paid - Common of $8000.0 as of Q4 2023, which was down 0.0% from $8000.0 recorded in Q4 2022.
  • Over the past 5 years, Ernexa Therapeutics' Dividends Paid - Common peaked at $8000.0 during Q4 2019, and registered a low of -$8000.0 during Q4 2020.
  • For the 4-year period, Ernexa Therapeutics' Dividends Paid - Common averaged around $4000.0, with its median value being $8000.0 (2019).
  • As far as peak fluctuations go, Ernexa Therapeutics' Dividends Paid - Common changed by 0.0% in 2019, and later crashed by 20000.0% in 2020.
  • Quarter analysis of 4 years shows Ernexa Therapeutics' Dividends Paid - Common stood at $8000.0 in 2019, then tumbled by 200.0% to -$8000.0 in 2020, then surged by 200.0% to $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023.
  • Its Dividends Paid - Common stands at $8000.0 for Q4 2023, versus $8000.0 for Q4 2022 and -$8000.0 for Q4 2020.